| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.005 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.094 | 0.005 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.009 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.079 | 0.01 |